A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-12-26
DOI
10.1002/pbc.28134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison between continuous and discrete doses for model based designs in cancer dose finding
- (2019) Márcio Augusto Diniz et al. PLoS One
- A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
- (2019) R. Tuli et al. EBioMedicine
- Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
- (2018) Arnauld Verschuur et al. Frontiers in Pharmacology
- mTOR as a central hub of nutrient signalling and cell growth
- (2018) Joungmok Kim et al. NATURE CELL BIOLOGY
- Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218
- (2018) Rebecca J. Deyell et al. PEDIATRIC BLOOD & CANCER
- A Bayesian adaptive design for cancer phase I trials using a flexible range of doses
- (2017) Mourad Tighiouart et al. Journal of Biopharmaceutical Statistics
- Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
- (2016) Pei Shi Ong et al. Frontiers in Pharmacology
- Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins
- (2015) Katherine H. Schreiber et al. AGING CELL
- Pilot study of a pediatric metronomic 4-drug regimen
- (2015) Nicolas André et al. Oncotarget
- Escalation with Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials
- (2014) Mourad Tighiouart et al. PLoS One
- Moving Forward with Metronomic Chemotherapy: Meeting Report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology
- (2014) Eddy Pasquier et al. Translational Oncology
- In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial
- (2013) Divya T. Koura et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies
- (2013) R D Harvey et al. BRITISH JOURNAL OF CANCER
- Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors
- (2013) Daniel A. Morgenstern et al. PEDIATRIC BLOOD & CANCER
- Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study
- (2013) Rochelle Bagatell et al. PEDIATRIC BLOOD & CANCER
- A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas
- (2012) Rajni Sinha et al. CANCER
- Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma
- (2011) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- Sirolimus in pediatric renal transplantation
- (2011) Belde Kasap PEDIATRIC TRANSPLANTATION
- A Phase I/II Trial Combining High-Dose Melphalan and Autologous Transplant with Bortezomib for Multiple Myeloma: A Dose- and Schedule-Finding Study
- (2010) S. Lonial et al. CLINICAL CANCER RESEARCH
- Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program
- (2010) P. J. Houghton et al. MOLECULAR CANCER THERAPEUTICS
- Rapamycin Pharmacokinetic and Pharmacodynamic Relationships in Osteosarcoma: A Comparative Oncology Study in Dogs
- (2010) Melissa C. Paoloni et al. PLoS One
- Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program
- (2007) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
- Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors
- (2007) L. Mi Rim Choi et al. PEDIATRIC BLOOD & CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started